The Role of Unfractionated Heparin in the Pathogenesis of Abnormal Lipid Metabolism in Hemodialysis Patients. Comparison With Low-Molecular-Weight Heparin.

Nihon Toseki Igakkai Zasshi
doi 10.4009/jsdt.27.355
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society for Dialysis Therapy

Related search

Low Molecular Weight Heparin or Unfractionated Heparin in the Treatment of Patients With Uncomplicated Deep Vein Thrombosis

Emergency Medicine Journal
MedicineCritical CareEmergency MedicineIntensive Care Medicine
2000English

Safety of Low-Molecular-Weight Heparin Compared to Unfractionated Heparin in Hemodialysis: A Systematic Review and Meta-Analysis

BMC Nephrology
Nephrology
2017English

Low Molecular Weight Heparin Versus Unfractionated Heparin for Thromboprophylaxis in Patients With Acute Atrial Fibrillation: A Randomized Control Trial

Acute Cardiac Care
Nuclear MedicineRadiologyEmergency MedicineCardiologyCardiovascular MedicineImaging
2011English

Low Molecular Weight Heparin

Journal of Cardiothoracic and Vascular Anesthesia
Cardiovascular MedicineAnesthesiologyPain MedicineCardiology
1992English

Low Molecular Weight Heparin

Reactions Weekly
2014English

Low Molecular Weight Heparin

Reactions Weekly
2013English

Low Molecular Weight Heparin

2020English

Unfractionated Heparin for Hemodialysis: Still the Best Option

Seminars in Dialysis
Nephrology
2010English

Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease : Fragmin in Unstable Coronary Artery Disease Study (FRIC)

Circulation
Cardiovascular MedicinePhysiologyCardiology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy